![Glenn Noronha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Noronha
Corporate Officer/Principal bij
The Association for Research in Vision & Ophthalmology
Profiel
Glenn Noronha is a professional with a doctorate degree from Loyola University of Chicago.
He is currently a member of The Association for Research in Vision & Ophthalmology.
In the past, he held positions such as Associate Director-Medicinal Chemistry at TargeGen, Project Head-Global Retinal Development at Alcon Laboratories, Vice President-Research & Development at Sucampo Pharma Americas, and Chief Scientific Officer at Clearside Biomedical, Theriac Pharma Corp., JW Therapeutics (Shanghai) Co., Ltd., Navire Pharma, Inc., and BridgeBio Pharma, Inc. He was also a Research Scientist & Project Leader at Medtronic MiniMed, Inc. from 2000 to 2002.
He will be the Chief Development Officer at PYC Therapeutics Ltd. from 2021 to 2023.
Actieve functies van Glenn Noronha
| Bedrijven | Functie | Begin |
|---|---|---|
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Corporate Officer/Principal | - |
Eerdere bekende functies van Glenn Noronha
| Bedrijven | Functie | Einde |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | 01-01-2023 |
| CLEARSIDE BIOMEDICAL | Hoofd Techniek/Wetenschap/O&O | 01-12-2018 |
Sucampo Pharma Americas, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-05-2013 |
Theriac Pharma Corp. | Hoofd Techniek/Wetenschap/O&O | 01-07-2012 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 01-01-2011 |
Opleiding van Glenn Noronha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
48
Eerstegraads connecties
12
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Medtronic MiniMed, Inc.
 Medtronic MiniMed, Inc. Medical SpecialtiesHealth Technology Manufactures insulin pumps and glucose monitoring systems | Health Technology |
The Association for Research in Vision & Ophthalmology
The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Commercial Services |
Sucampo Pharma Americas, Inc. | |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Theriac Pharma Corp. | |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
